Jun 10, 2019 / 12:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Sesen Bio Regulatory Update June 2019 Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Ms. Erin Clark, Executive Director of Strategic Planning and Investor Relations. Ma'am, you may begin.
Erin Clark - Sesen Bio, Inc. - Executive Director, Strategic Planning & IR
Thank you, and good morning. Welcome to today's conference call. On today's call Dr. Thomas Cannell, our President and CEO, will discuss the outcomes of our recent FDA meetings and provide an update on our regulatory path forward. In addition to Dr. Cannell, on the call with me today are Dr. Dennis Kim, Chief Medical Officer; Richard Fitzgerald, Chief Financial Officer; and Dr. Chad Myskiw, Strategic Planning and CMC.
Earlier this morning, we issued a press release outlining the highlights that will be covered on the call today. The press release and the slides to which we will refer are available on the Investors section
Sesen Bio Inc Regulatory Update June 2019 Transcript
Jun 10, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers